SC
SAGE

Slotnik Capital’s Sage Therapeutics SAGE Stock Holding History

Slotnik Capital’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-166,592
Closed -$1.52M – 39
2025
Q2 		$1.52M Buy
+166,592
New +$1.23M 0.58% 21

Other funds holding SAGE

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Slotnik Capital's SAGE Position: Q3 2025 in Review

Slotnik Capital sold out of Sage Therapeutics (SAGE) in Q3 2025, closing a stake of 166,592 shares — an estimated $1.52M sold.

Slotnik Capital first reported a position in SAGE in Q2 2025 and held it in 1 quarter. The position peaked at $1.52M in Q2 2025. 5 funds tracked by Wall St. Rank hold SAGE as of Q3 2025.

  • Slotnik Capital reported no remaining Sage Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Slotnik Capital sold 166,592 Sage Therapeutics shares in Q3 2025, an estimated $1.52M.
  • Slotnik Capital first reported a position in Sage Therapeutics in Q2 2025 and held it in 1 quarter.
  • Slotnik Capital's Sage Therapeutics position peaked at $1.52M in Q2 2025.
  • 5 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2025.

Based on Slotnik Capital's 13F filing for Q3 2025, filed 13 Nov 2025.